TL5: Randomized Withdrawal Design
*Ha Hung Nguyen, Pfizer Inc Keywords: Randomized withdrawal design had been used in many therapeutic areas (psychiatry, pain, ..) as a mean to enrich the population, reduce the placebo response… However, because of the nature of its design, Randomized Withdrawal studies should be interpreted cautiously as it could not be easily generalized. In this roundtable luncheon, we will discuss and share experiences in summarizing efficacy and safety results from Randomized Withdrawal Studies and challenges that one faces in using randomized withdrawal studies in a filing for a new indication.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC